Our study elucidates the novel mechanism by which oncoVV-AVL induces metabolic reprogramming in HCC through the ACSS2/TFEB axis, bridging viral oncolysis with host lipid–autophagy crosstalk. The gene discussed is TFEB; the disease is hepatocellular carcinoma.